ArticleExperimental and therapeutic medicine2018

Farnesyltransferase inhibitors prevent HIV protease inhibitor (lopinavir/ritonavir)-induced lipodystrophy and metabolic syndrome in mice.

Tomokazu Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.